미국 · 보도자료 · Aligos Therapeutics · 2026-10-05 20:05
간 학회 2026서 초록 5건 발표 확정
SOUTH SAN FRANCISCO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced five abstracts have been accepted for presentation at the American Association for the Study of Liver Disease’s (AASLD) The Liver Meetin
Aligos Therapeutics 다른 공시·급등 이유 보기 · GK의 공시레이더 — 미국·한국 실시간 공시
